Navigation Links
Artikel im American Journal of Cardiology zeigt gute Gefäßheilung nach MiStent-SES-Implantation
Date:11/21/2013

sgabe des American Journal of Cardiology vom 15. November 2013 erschien der Artikel „Serial Assessment of Early and Late Vascular Responses After Implantation of an Absorbable-Coating Sirolimus-Eluting Stent: An Optical Coherence Tomography Sub-Study From The First-in-Human DESSOLVE I Trial." Hauptautor dieses Artikels ist Guilherme Attizzani, M.D., wissenschaftlicher Mitarbeiter am Harrington Heart and Vascular Institute des University Hospitals Case Medical Center.

Informationen zum MiStent SES

Das MiStent Sirolimus-eluierende Koronarstentsystem aus resorbierbarem Polymer (MiStent SES®) wurde speziell für die optimierte Heilung in Patienten mit koronarer Herzerkrankung entwickelt. Die schnell resorbierbare Beschichtung des MiStent SES soll die Arzneimittelfreisetzung genauestens und konsistent steuern und die Polymer-Expositionsdauer begrenzen. Dies wirkt sich vorteilhaft auf die Sicherheitsrisiken bei derzeit am Markt erhältlichen Arzneimittel-eluierenden Stent-Technologien aus.

Das innovative MiStent-SES-System besitzt eine neuartige Stentbeschichtung mit einem kristallinen Wirkstoff (Sirolimus) und einem resorbierbarem Polymer. Die Beschichtung sorgt für eine kontrollierte und anhaltende Freisetzung therapeutischer Arzneimitteldosen, während das Polymer weich wird und sich vom Stent in das benachbarte Gewebe ablöst. Diese Eigenschaften sollen sich gegenüber herkömmlichen Dauer-Polymer-DES vorteilhaft auf die Sicherheit auswirken.

Durch den Einsatz eines zugelassenen Wirkstoffs (Sirolimus) und die Verwendung von Polymer (PLGA) ermöglicht die von Micell patentierte überkritische Fluidtechnologie das Auftragen einer streng kontrollierten Wirkstoff-Polymer-Beschichtung auf einen blanken Metallstent. Das MiStent SES nutzt die Vorteile des (CE-zertifizierten) Eurocor Genius® MAGIC Cobaltchrom-Koronars
'/>"/>

SOURCE Micell Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... DIEGO , Nov. 24, 2014  GlySens Incorporated ... two million dollar grant from the National Institute of ... of the National Institutes of Health (NIH).  The grant ... GlySens second generation ICGM™ long term implantable glucose monitoring ... underway, and enrollment is expected to begin before the ...
(Date:11/24/2014)... Pa. , Nov. 24, 2014  Inovio Pharmaceuticals, Inc. ... J. Joseph Kim , President and CEO of Inovio Pharmaceuticals, ... management team to ring the Nasdaq Opening Bell tomorrow, Tuesday ... Inovio,s September 15 th listing on the Nasdaq Global ... ceremony, Dr. Kim said, "We are honored to ring the ...
(Date:11/22/2014)... 2014  New data demonstrates that flibanserin, a novel, ... of female sexual dysfunction, Hypoactive Sexual Desire Disorder (HSDD), ... in premenopausal women when taken at bedtime. The data ... North America,s (SMSNA) 20th Annual Fall ... SMSNA accepted this study as a late ...
Breaking Medicine Technology:GlySens Incorporated Awarded $2 Million Grant from the National Institutes of Health 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 2Inovio Pharmaceuticals to Ring Opening Bell Nov 25th on the Nasdaq Stock Market 3Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3
... The National,Comprehensive Cancer Network (NCCN) announces updates to ... Cancer,and Gastric Cancer. The NCCN Guidelines are updated ... recognized and,applied as the standard of care in ... and the academic practice settings., In response to ...
... of the Most Challenging Patient Populations,Studied of Any ... PARK, Calif., May 22, 2007,/PRNewswire-FirstCall/ -- XTENT, Inc. ... clinical trial, which assessed,the safety and efficacy of ... for the treatment of long and,multiple lesions in ...
Cached Medicine Technology:NCCN Updates Esophageal and Gastric Cancer Guidelines 2NCCN Updates Esophageal and Gastric Cancer Guidelines 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 2XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 3XTENT Announces Promising Six-Month Custom II Trial Data Presented,at EuroPCR Meeting 4
(Date:11/24/2014)... 24, 2014 Gersowitz Libo & Korek, P.C., ... received national Tier recognition in the 2015 Edition of U.S. ... ranking signals a unique combination of quality law practice and ... receive this honor and especially grateful to our clients whose ... and ranking possible,” said Jeff S. Korek, senior partner at ...
(Date:11/23/2014)... iFitDress.com, a well-known wedding dress manufacturer, has unveiled ... They are now offered at deeply discounted prices, up ... now to Dec. 15. The main purpose of the promotion ... high quality items are ideal options for ladies who are ... money. All its new mint cocktail dresses are very beautiful; ...
(Date:11/23/2014)... November 23, 2014 Pro Ace Care, a ... it will now be providing an 8 year warranty on ... water tank installations went up due to the impending winter ... its customers of the premium service that the company provides. ... year warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... More than two dozen new claims ... litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), as well ... reports. , A Case List updated on November ... Type 2 diabetes medications referred to as incretin mimetics ... Southern District of California, where a federal proceeding continues ...
Breaking Medicine News(10 mins):Health News:U.S. News-Best Lawyers “Best Law Firms” Names Gersowitz Libo & Korek P.C. a 2015 Tier 1 Ranking Firm 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4
... after women have separated from an abusive partner, the violence still ... at the University of British Columbia. Led by UBC Nursing ... of Canadian Public Policy is the first in ... used by women who leave a violent partner. Overall, ...
... and Reinvestment Act award from the Agency for Healthcare ... Indiana Network for Patient Care (INPC), the nation,s largest ... simultaneously supports a groundbreaking comparative effectiveness research study using ... harms of three drugs commonly used to treat Alzheimer,s ...
... A pioneering international collaboration forged by Fred Hutchinson ... with the Uganda Cancer Institute in Kampala, Uganda, ... a state-of-the-art cancer training and outpatient treatment facility ... comprehensive cancer center jointly constructed by U.S. and ...
... by University of Cincinnati (UC) faculty members shows that ... clinical experience helps internal medicine residents improve their scores ... findings, published in the advance online edition of the ... print in November, validate the benefit of this and ...
... of 606 Canadian physicians were disciplined by their provincial ... St. Michael,s Hospital found. The majority of disciplined ... practicing medicine for a long time (an average of ... according to Dr. Chaim Bell. The most frequent ...
... wild, poisonous mushroom growing in a Southwest China forest appears ... report. , The compound, verticillin A, sensitizes cancer cells to ... said Dr. Kebin Liu, cancer immunologist at the Georgia Health ... in the journal Cancer Research . , The compound ...
Cached Medicine News:Health News:Annual cost of violence pegged at $6.9 billion after women leave abusive partners, UBC research 2Health News:$8.4 million grant supports health information exchange and research on Alzheimer's drugs 2Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 2Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 3Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 4Health News:Hutchinson Center breaks ground for first collaborative cancer center in sub-Saharan Africa 5Health News:New testing program improves scores, knowledge retention for third-year internal medicine residents 2Health News:New testing program improves scores, knowledge retention for third-year internal medicine residents 3Health News:Researchers track number of doctors disciplined and why 2Health News:Mushroom compound appears to improve effectiveness of cancer drugs 2
ISYSTEM-ABDv2™A/B Scan unit. True Geometry With Stepped Zoom, Pan, Freeze Frame, Post Image Processing....
... The CineScan A/B represent a true ... analog image with technology and diagnostic capability ... in the vitreous. Adjust the gain up ... would be invisible at a standard 90db ...
PremierEdge Stab Knives - 30....
PremierEdge™ Stab Knives - 15°....
Medicine Products: